MRes Studentship part 2

I’m excited to be starting my second MRes project at TAC. Under the supervision of both Eric Wagner and Mark Williams I will be carrying out antigen affinity purification to produce a pool of polyclonal antibodies against an expressed cell surface receptor on multiple myeloma cells, the cell culture of primary human myeloma cell lines to determine both binding by FACS and cell killing ability of the polyclonal antibodies.

In conjunction with this project a series of proof-of-concept experiments will be carried out, involving: the transfection of a full IgG-expressing plasmid into CHO cells, antibody screening, and purification.

Posted in

Why use us?

  • Rapid and competitive quotation
  • Flexible project start and end points
  • Experienced team and project management
  • Real-time project updates and technical support
  • No customs delays, no duty and overseas shipping for UK based companies
  • Same day shipping
  • Specialist problem solvers

Virtual Lab for early stage companies

De-risk promising early stage technology by using The Antibody Company's integrated research and production facilities and over 20 years' experience for developing diagnostics and therapeutics. Our Virtual Lab packages can speed up the process and save significant up-front expenditure on specialist equipment and staff.

We offer our Virtual Lab expertise for assistance and partnering in grant and commercial applications.


Talk to us about a service

The Antibody Company offers competitive pricing for single phase or the entire process of generating high-quality monoclonal antibodies and assays.

Scroll to Top